Clover Health Investments, Corp.
CLOV
$4.60
$0.112.45%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 737.77M | 744.19M | 485.87M | 479.13M | 469.83M |
| Total Other Revenue | 5.40M | 5.00M | 1.84M | 16.72M | 7.79M |
| Total Revenue | 743.17M | 749.19M | 487.71M | 495.85M | 477.62M |
| Cost of Revenue | 590.17M | 589.65M | 413.50M | 423.47M | 377.99M |
| Gross Profit | 153.00M | 159.54M | 74.21M | 72.38M | 99.63M |
| SG&A Expenses | 124.44M | 131.69M | 123.11M | 97.15M | 109.79M |
| Depreciation & Amortization | 564.00K | 515.00K | 420.00K | 406.00K | 394.00K |
| Other Operating Expenses | -- | -- | 0.00 | -800.00K | -- |
| Total Operating Expenses | 715.17M | 721.86M | 537.03M | 520.23M | 488.18M |
| Operating Income | 28.00M | 27.33M | -49.32M | -24.38M | -10.56M |
| Income Before Tax | 28.00M | 27.33M | -49.32M | -24.38M | -10.58M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 28.00M | 27.33M | -49.32M | -24.38M | -10.58M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 28.00M | 27.33M | -49.32M | -24.38M | -10.58M |
| EBIT | 28.00M | 27.33M | -49.32M | -24.38M | -10.56M |
| EBITDA | 28.57M | 27.85M | -48.90M | -23.97M | -10.17M |
| EPS Basic | 0.05 | 0.05 | -0.10 | -0.05 | -0.02 |
| Normalized Basic EPS | 0.03 | 0.03 | -0.06 | -0.03 | -0.01 |
| EPS Diluted | 0.05 | 0.05 | -0.10 | -0.05 | -0.02 |
| Normalized Diluted EPS | 0.03 | 0.03 | -0.06 | -0.03 | -0.01 |
| Average Basic Shares Outstanding | 524.19M | 522.18M | 517.24M | 512.74M | 509.04M |
| Average Diluted Shares Outstanding | 545.45M | 522.18M | 517.24M | 512.74M | 509.04M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |